28402261|t|Association of CKIP-1 P21A polymorphism with risk of chronic heart failure in a Chinese population
28402261|a|Pathological cardiac hypertrophy is an independent risk factor for chronic heart failure. Casein kinase-2 interacting protein-1 (CKIP-1) can inhibit pathological cardiac hypertrophy. Therefore, we investigated whether CKIP-1 nonsynonymous polymorphism rs2306235 (Pro21Ala) contributes to risk and prognosis of chronic heart failure in a Chinese population. A total of 923 adult patients with chronic heart failure and 1020 age - and gender -matched healthy controls were recruited. CKIP-1 rs2306235 polymorphism was genotyped using PCR - restriction fragment length polymorphism. Additional follow-up data for 140 chronic heart failure patients was evaluated. The rs2306235 G allele was associated with an increased risk of chronic heart failure (OR = 1.38, 95% CI = 1.09-1.75, p = 0.007), especially in patients with hypertension (OR = 1.45, 95% CI = 1.09-1.75, p = 0.006) and coronary heart disease (OR = 1.41, 95% CI = 1.09-1.83, p = 0.010) after adjustment for multiple cardiovascular risk factors. However, rs2306235 polymorphism was not associated with cardiovascular mortality in chronic heart failure (p = 0.875). CKIP-1 rs2306235 polymorphism may be a risk factor for chronic heart failure in a Chinese Han population.
28402261	15	26	CKIP-1 P21A	T017	UMLS:C1826600
28402261	27	39	polymorphism	T082	UMLS:C0752046
28402261	53	74	chronic heart failure	T038	UMLS:C0264716
28402261	80	98	Chinese population	T098	UMLS:C0152035
28402261	112	131	cardiac hypertrophy	T038	UMLS:C1383860
28402261	150	161	risk factor	T033	UMLS:C0035648
28402261	166	187	chronic heart failure	T038	UMLS:C0264716
28402261	189	226	Casein kinase-2 interacting protein-1	T103	UMLS:C1309499
28402261	228	234	CKIP-1	T103	UMLS:C1309499
28402261	261	280	cardiac hypertrophy	T038	UMLS:C1383860
28402261	317	323	CKIP-1	T017	UMLS:C1826600
28402261	324	360	nonsynonymous polymorphism rs2306235	T082	UMLS:C0752046
28402261	362	370	Pro21Ala	T038	UMLS:C0026882
28402261	396	405	prognosis	T058	UMLS:C0033325
28402261	409	430	chronic heart failure	T038	UMLS:C0264716
28402261	436	454	Chinese population	T098	UMLS:C0152035
28402261	491	512	chronic heart failure	T038	UMLS:C0264716
28402261	581	597	CKIP-1 rs2306235	T017	UMLS:C1826600
28402261	598	610	polymorphism	T082	UMLS:C0752046
28402261	615	624	genotyped	T058	UMLS:C1285573
28402261	631	634	PCR	T062	UMLS:C0032520
28402261	637	677	restriction fragment length polymorphism	T058	UMLS:C3714764
28402261	690	699	follow-up	T058	UMLS:C1522577
28402261	713	734	chronic heart failure	T038	UMLS:C0264716
28402261	748	757	evaluated	T058	UMLS:C0220825
28402261	763	772	rs2306235	T017	UMLS:C1826600
28402261	773	781	G allele	T017	UMLS:C0002085
28402261	823	844	chronic heart failure	T038	UMLS:C0264716
28402261	917	929	hypertension	T038	UMLS:C0020538
28402261	977	999	coronary heart disease	T038	UMLS:C0010068
28402261	1088	1100	risk factors	T033	UMLS:C0035648
28402261	1111	1120	rs2306235	T017	UMLS:C1826600
28402261	1121	1133	polymorphism	T082	UMLS:C0752046
28402261	1186	1207	chronic heart failure	T038	UMLS:C0264716
28402261	1221	1237	CKIP-1 rs2306235	T017	UMLS:C1826600
28402261	1238	1250	polymorphism	T082	UMLS:C0752046
28402261	1260	1271	risk factor	T033	UMLS:C0035648
28402261	1276	1297	chronic heart failure	T038	UMLS:C0264716